Search

Jonathan S. Lau

Examiner (ID: 8893, Phone: (571)270-3531 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1623, 1673
Total Applications
1249
Issued Applications
700
Pending Applications
107
Abandoned Applications
463

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19265317 [patent_doc_number] => 20240209016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => FLUORESCENT NUCLEOSIDE PHOSPHATES [patent_app_type] => utility [patent_app_number] => 18/555180 [patent_app_country] => US [patent_app_date] => 2022-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555180 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/555180
FLUORESCENT NUCLEOSIDE PHOSPHATES Apr 10, 2022 Pending
Array ( [id] => 19279940 [patent_doc_number] => 20240216413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => THIONUCLEOSIDES AS ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 18/285789 [patent_app_country] => US [patent_app_date] => 2022-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285789 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/285789
THIONUCLEOSIDES AS ANTIVIRAL AGENTS Apr 10, 2022 Pending
Array ( [id] => 20824861 [patent_doc_number] => 12678403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-14 [patent_title] => Pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver containing Polygalin C as active ingredient [patent_app_type] => utility [patent_app_number] => 18/287015 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 0 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287015 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/287015
Pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver containing Polygalin C as active ingredient Apr 7, 2022 Issued
Array ( [id] => 19246776 [patent_doc_number] => 20240197760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => ACTIVATORS OF INTEGRATED STRESS RESPONSE PATHWAY FOR PROTECTION AGAINST FERROPTOSIS [patent_app_type] => utility [patent_app_number] => 18/285815 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285815 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/285815
ACTIVATORS OF INTEGRATED STRESS RESPONSE PATHWAY FOR PROTECTION AGAINST FERROPTOSIS Apr 7, 2022 Pending
Array ( [id] => 17749977 [patent_doc_number] => 20220228182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => STARCH-DERIVED CLATHRATE-FORMING COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/712349 [patent_app_country] => US [patent_app_date] => 2022-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712349 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/712349
Starch-derived clathrate-forming compositions Apr 3, 2022 Issued
Array ( [id] => 17749978 [patent_doc_number] => 20220228183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => STARCH-DERIVED CLATHRATE-FORMING COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/712405 [patent_app_country] => US [patent_app_date] => 2022-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712405 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/712405
Starch-derived clathrate-forming compositions Apr 3, 2022 Issued
Array ( [id] => 20212553 [patent_doc_number] => 12409187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => PH regulating hydrogels that neutralize cancer cell environment acidosis and increase chemotherapy efficacy [patent_app_type] => utility [patent_app_number] => 17/710505 [patent_app_country] => US [patent_app_date] => 2022-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 22 [patent_no_of_words] => 20237 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710505 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/710505
PH regulating hydrogels that neutralize cancer cell environment acidosis and increase chemotherapy efficacy Mar 30, 2022 Issued
Array ( [id] => 19310418 [patent_doc_number] => 12036212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-16 [patent_title] => Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent [patent_app_type] => utility [patent_app_number] => 17/705798 [patent_app_country] => US [patent_app_date] => 2022-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 49 [patent_no_of_words] => 20436 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705798 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/705798
Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent Mar 27, 2022 Issued
Array ( [id] => 18348219 [patent_doc_number] => 20230136330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => ANTIMICROBIAL AND/OR EPITHELIAL CELL GROWTH STIMULATING SUBSTANCE AND COMPOSITION AND TISSUE DRESSING MATERIAL [patent_app_type] => utility [patent_app_number] => 17/698086 [patent_app_country] => US [patent_app_date] => 2022-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698086 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/698086
Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material Mar 17, 2022 Issued
Array ( [id] => 18739561 [patent_doc_number] => 20230348515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => NOVEL SOPHOROLIPID DERIVATIVE [patent_app_type] => utility [patent_app_number] => 18/016898 [patent_app_country] => US [patent_app_date] => 2022-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016898 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/016898
NOVEL SOPHOROLIPID DERIVATIVE Mar 17, 2022 Abandoned
Array ( [id] => 19279934 [patent_doc_number] => 20240216407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => NOVEL POLYPHENOL COMPOUND [patent_app_type] => utility [patent_app_number] => 18/285600 [patent_app_country] => US [patent_app_date] => 2022-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5588 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285600 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/285600
NOVEL POLYPHENOL COMPOUND Mar 13, 2022 Pending
Array ( [id] => 17937043 [patent_doc_number] => 11471475 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-10-18 [patent_title] => Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery [patent_app_type] => utility [patent_app_number] => 17/689219 [patent_app_country] => US [patent_app_date] => 2022-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15705 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689219 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/689219
Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery Mar 7, 2022 Issued
Array ( [id] => 17851960 [patent_doc_number] => 20220282002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => USE OF CATALYTIC ION EXCHANGE RESINS TO EFFECTIVELY DECOLORIZE POLYSACCHARIDES DERIVED FROM LIGNOCELLULOSIC BIOMASS [patent_app_type] => utility [patent_app_number] => 17/684856 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684856 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/684856
USE OF CATALYTIC ION EXCHANGE RESINS TO EFFECTIVELY DECOLORIZE POLYSACCHARIDES DERIVED FROM LIGNOCELLULOSIC BIOMASS Mar 1, 2022 Abandoned
Array ( [id] => 19142244 [patent_doc_number] => 20240141074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => Method of Producing Cellulose Carbamate [patent_app_type] => utility [patent_app_number] => 18/279078 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8243 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279078 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/279078
Method of producing cellulose carbamate Feb 27, 2022 Issued
Array ( [id] => 19096482 [patent_doc_number] => 20240115709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => ASSEMBLY OF ORGANIC SUPRAMOLECULAR VESSELS FOR CONTROLLED DRUG RELEASE [patent_app_type] => utility [patent_app_number] => 18/277195 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18043 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277195 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277195
ASSEMBLY OF ORGANIC SUPRAMOLECULAR VESSELS FOR CONTROLLED DRUG RELEASE Feb 24, 2022 Pending
Array ( [id] => 19691228 [patent_doc_number] => 20250009773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND VITAMIN B6 [patent_app_type] => utility [patent_app_number] => 18/547932 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547932 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/547932
COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND VITAMIN B6 Feb 22, 2022 Pending
Array ( [id] => 18018846 [patent_doc_number] => 20220370345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => METHODS, AGENTS, AND DEVICES FOR LOCAL NEUROMODULATION OF AUTONOMIC NERVES [patent_app_type] => utility [patent_app_number] => 17/669778 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28528 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669778 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/669778
Methods, agents, and devices for local neuromodulation of autonomic nerves Feb 10, 2022 Issued
Array ( [id] => 18931012 [patent_doc_number] => 11883406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Method for producing alginic acid-folic acid conjugate, alginic acid-folic acid conjugate produced thereby and pharmaceutical composition containing the same [patent_app_type] => utility [patent_app_number] => 17/590217 [patent_app_country] => US [patent_app_date] => 2022-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 6814 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590217 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/590217
Method for producing alginic acid-folic acid conjugate, alginic acid-folic acid conjugate produced thereby and pharmaceutical composition containing the same Jan 31, 2022 Issued
Array ( [id] => 19150127 [patent_doc_number] => 11975017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-07 [patent_title] => Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections [patent_app_type] => utility [patent_app_number] => 17/585651 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12181 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585651 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/585651
Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections Jan 26, 2022 Issued
Array ( [id] => 20911805 [patent_doc_number] => 12708640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-08-18 [patent_title] => Synergistic nutritional compositions for treating vestibular associated neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 18/273749 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6709 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273749 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/273749
SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR TREATING VESTIBULAR ASSOCIATED NEURODEGENERATIVE DISEASES Jan 20, 2022 Pending
Menu